New Drug Protects Against Radiation Damage
...ancy, and so can grow indefinitely, Gudkov said. "So, we decided to imitate pharmacologically what tumors do genetically," he said. Like flagellin, cblb502 does not act directly on apoptosis, he said. Instead, it stimulates cells in the body to make substances that give protection. A first request for ...Cleveland BioLabs to Present Protectan CBLB502 at 2008 BARDA Day ...
Cleveland BioLabs to Present Protectan CBLB502 at 2008 BARDA Day. - BUFFALO, NY--(MARKET WIRE)--Sep 23, 2008 -- Cleveland BioLabs, Inc. (NasdaqGM:CBLI - News) ...Cleveland BioLabs Doses First Healthy Volunteer in Initial Safety Study ...
Cleveland BioLabs Doses First Healthy Volunteer in Initial Safety Study for Protectan CBLB502. - BUFFALO, NY--(MARKET WIRE)--Oct 15, 2008 -- Cleveland BioLabs, ...Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Survival ...
Cleveland BioLabs, Inc. (Nasdaq: CBLI; BSE: CFB), announced today the results of its study of Protectan CBLB502's efficacy as a mitigator of both gastrointestinal ...Cleveland BioLabs Protectan CBLB502 Demonstrates Strong Mitigation Of ...
Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced that recent primate studies have demonstrated the efficacy of Cleveland BioLabs's Protectan CBLB502 as a mitigator ...News: Cleveland BioLabs Receives First U.S. Patent Allowance for Its ...
Cleveland BioLabs, Inc. (NASDAQ: CBLI) announced today that it has received a Notice of Allowance from the U.S. Patent ... Evidence of CBLB502's mechanism of ...